O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia

O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia

Removal of 9-O-acetyl residues from the cell surface N-acetylneuraminic acid makes ALL cells drug sensitive.

Bibliographic Details
Main Authors:	Parameswaran, Reshmi, Lim, Min, Arutyunyan, Anna, Abdel-Azim, Hisham, Hurtz, Christian, Lau, Kam, Müschen, Markus, Yu, Robert K., von Itzstein, Mark, Heisterkamp, Nora, Groffen, John
Format:	Online
Language:	English
Published:	The Rockefeller University Press 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620349/

Similar Items

Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonist
by: Parameswaran, Reshmi, et al.
Published: (2011)

Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxin
by: Parameswaran, Reshmi, et al.
Published: (2012)

Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia
by: Kaur, Pavinder, et al.
Published: (2007)

Environment-mediated drug resistance in Bcr/Abl-positive acute lymphoblastic leukemia
by: Feldhahn, Niklas, et al.
Published: (2012)

B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3
by: Fei, Fei, et al.
Published: (2015)

Cytotoxicity of CD56-positive lymphocytes against autologous B-cell precursor acute lymphoblastic leukemia cells
by: Fei, Fei, et al.
Published: (2014)

Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008
by: Helicia Paz, et al.
Published: (2018-03-01)

Treatment of human pre-B acute lymphoblastic leukemia with the Aurora kinase inhibitor PHA-739358 (Danusertib)
by: Fei, Fei, et al.
Published: (2012)

Phosphoflow-Based Evaluation of Mek Inhibitors as Small-Molecule Therapeutics for B-Cell Precursor Acute Lymphoblastic Leukemia
by: George, Aswathi A., et al.
Published: (2015)

AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo
by: Yu, M, et al.
Published: (2011)

Lack of Bcr and Abr Promotes Hypoxia-Induced Pulmonary Hypertension in Mice
by: Yu, Min, et al.
Published: (2012)

Expression of cassini, a murine gamma-satellite sequence conserved in evolution, is regulated in normal and malignant hematopoietic cells
by: Arutyunyan, Anna, et al.
Published: (2012)

Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia
by: Zhang, Cheng, et al.
Published: (2015)

Eosinophilic presentation of acute lymphoblastic leukemia
by: Rezamand, Azim, et al.
Published: (2013)

Pre–B cell receptor–mediated cell cycle arrest in Philadelphia chromosome–positive acute lymphoblastic leukemia requires IKAROS function
by: Trageser, Daniel, et al.
Published: (2009)

Synthesis of Partially O-Acetylated N-Acetylneuraminic Acid Using Regioselective Silyl Exchange Technology
by: Park, Simon S., et al.
Published: (2014)

BCL6 enables Ph+ acute lymphoblastic leukemia cells to survive BCR-ABL1 kinase inhibition
by: Duy, Cihangir, et al.
Published: (2011)

COLOMINIC ACID, A POLYMER OF N-ACETYLNEURAMINIC ACID
by: Barry, Guy T.
Published: (1958)

Infectious origins of childhood leukemia
by: Swaminathan, Srividya, et al.
Published: (2015)

The BCR-ABL1 Kinase Bypasses Selection for the Expression of a Pre–B Cell Receptor in Pre–B Acute Lymphoblastic Leukemia Cells
by: Klein, Florian, et al.
Published: (2004)

Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia
by: Swaminathan, Srividya, et al.
Published: (2015)

Mimicry of a constitutively active pre–B cell receptor in acute lymphoblastic leukemia cells
by: Feldhahn, Niklas, et al.
Published: (2005)

Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1–transformed acute lymphoblastic leukemia cells
by: Feldhahn, Niklas, et al.
Published: (2007)

Acute lymphoblastic leukemia in adults
by: Ribera, Josep-Maria
Published: (2011)

Analysis of mammary tumour cell metastasis and release of bound n-acetylneuraminic acid.
by: Hoon, D. B., et al.
Published: (1985)

Leukemia cutis in a patient with pre–B-cell acute lymphoblastic leukemia
by: Campuzano-García, Andrés Eduardo, et al.
Published: (2015)

Signaling thresholds and negative B cell selection in acute lymphoblastic leukemia
by: Chen, Zhengshan, et al.
Published: (2015)

Acute lymphoblastic leukemia: age and biology
by: Foà, Robin
Published: (2011)

Diagnosis and Subclassification of Acute Lymphoblastic Leukemia
by: Chiaretti, Sabina, et al.
Published: (2014)

Pathogenesis and prognostication in acute lymphoblastic leukemia
by: Zuckerman, Tsila, et al.
Published: (2014)

Genetic and epigenetic characterization of hypodiploid acute lymphoblastic leukemia
by: Safavi, Setareh, et al.
Published: (2015)

Proteomic profile of pre - B2 lymphoblasts from children with acute lymphoblastic leukemia (ALL) in relation with the translocation (12; 21)
by: Costa, Odile, et al.
Published: (2014)

YM155 potently kills acute lymphoblastic leukemia cells through activation of the DNA damage pathway
by: Chang, Bill H, et al.
Published: (2015)

Pancytopenic Prodrome (pre-ALL) of Acute Lymphoblastic Leukemia in Adults: Possible Pathogenesis
by: Sohn, Sang Kyun, et al.
Published: (1998)

Potential of ponatinib to treat chronic myeloid leukemia and acute lymphoblastic leukemia
by: Price, Kimberly E, et al.
Published: (2013)

Leukemia Cutis: An Unusual Presentation of Acute Lymphoblastic Leukemia in a Child
by: Jiang, Xia, et al.
Published: (2015)

Characterization and identification of leukemia initiating cells in pediatric acute lymphoblastic leukemia
by: Trentin, Luca, et al.
Published: (2014)

First-line treatment of acute lymphoblastic leukemia with pegasparaginase
by: Masetti, Riccardo, et al.
Published: (2009)

Optic nerve infiltration in relapse of acute lymphoblastic leukemia
by: Ali, Mohammad Javed, et al.
Published: (2011)

Emerging Pharmacotherapies for Adult Patients with Acute Lymphoblastic Leukemia
by: Lee, Lydia, et al.
Published: (2012)